An open-label, randomized, parallel group study comparing the efficacy and safety of amlodipine in combination with valsartan compared to losartan in combination with hydrochlorothiazide given for 52 weeks on the regression of left ventricular hypertrophy in patients with mild to moderate hypertension.

Trial Profile

An open-label, randomized, parallel group study comparing the efficacy and safety of amlodipine in combination with valsartan compared to losartan in combination with hydrochlorothiazide given for 52 weeks on the regression of left ventricular hypertrophy in patients with mild to moderate hypertension.

Completed
Phase of Trial: Phase III

Latest Information Update: 21 Jul 2011

At a glance

  • Drugs Amlodipine; Hydrochlorothiazide; Losartan; Valsartan
  • Indications Essential hypertension
  • Focus Therapeutic Use
  • Sponsors Novartis
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 26 Apr 2011 Actual end date (1 Mar 2010) added as reported by ClinicalTrials.gov.
    • 26 Apr 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top